Furthermore, an elevated methylation level of 10 CpG sites in the QKI promoter was found in the CRC of the test set A, and five of six CpG sites had a stable performance in distinguishing 305 CRC patients from 386 normal tissues (average AUC = 0.863). The gene discussed is QKI; the disease is colorectal carcinoma.